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ABSTRACT
The common diagnostic methods to know primary hemostasis have been classified as invasive, depending on the operator, 
difficult to reproduce and at times not very reliable. Thus, different systems have been proposed to assess bleeding time, 
one of them being the PFA-100 device, which we present in this paper.
Objective: Compare specificity between the traditional Ivy method with the PFA-100 system to measure bleeding 
time.
Material and method: We obtained a sample of 33 patients between the age of 24-80 years receiving anti-platelet treatment 
who needed to undergo oral surgery. Bleeding time was obtained by the Ivy method, an INR by an analysis done on the 
same day and a Coagucheck one hour before surgery as well as measurement of bleeding time with the PFA-100 system.
Results: Mean value of bleeding time through the Ivy method was 406.36 sec.. Mean bleeding time with the PFA-100 
system for the collagen/epinephrine cartridge was 226.91 sec. and for the collagen/ADP cartridge was 110.27 sec.. All 
these values were within normality. We observed very high standard deviations with the Ivy method and more regular 
ones for the PFA-100 system, indicating its greater specificity. We also obtained a large correlation between collagen/
epinephrine cartridge and acetylsalicylic acid.
Conclusions: We found greater specificity of the analyzer of PFA-100 platelet function for the measurement of bleeding 
time in relationship with the traditional Ivy method.
Key words: PFA, bleeding time.
RESUMEN
Los métodos diagnósticos habituales para conocer la hemostasia primaria han sido calificados como cruentos, depen-
dientes del operador, de difícil reproducción y en ocasiones no muy fiables. Es por ello que se han propuesto diferentes 
sistemas para valorar el tiempo de hemorragia, siendo uno de ellos el dispositivo PFA-100, el cual presentamos en este 
trabajo.
Objetivo: Comparar la especificidad entre el método tradicional Ivy con el sistema PFA-100 para la determinación del 
tiempo de hemorragia.
Material y método: Obtuvimos una  muestra de 33 pacientes de entre 24-80 años en tratamiento antiplaquetario a los 
cuales se debía realizar una cirugía oral. Se les realizó un tiempo de hemorragia  mediante el método Ivy , un INR me-
diante una analítica realizada el mismo día y un Coagucheck una hora antes de la cirugía así como la determinación del 
tiempo de sangrado mediante el dispositivo PFA-100.
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INTRODUCTION
Currently, and thanks to the increase of  well-designed 
randomized clinical studies that establish their indication, 
optimum dose and duration of administration, efficacy of 
the platelet antiaggregant agents has been confirmed in the 
prevention and treatment of thromboembolic disease (1). In 
the last decade, the treatment regime with aspirin has beco-
me enormously popular (2, 3). The number of patients who 
come to our out-patient clinic with antiaggregant treatment 
as therapy for cardiovascular and peripheral vascular disea-
ses, such as, for example, ischemic heart disease, valvular 
prosthesis, venous thrombosis, etc., is increasingly greater. 
Furthermore, there is an increasing majority opinion not to 
suspend anticoagulant or platelet antiaggregant treatment 
before the surgical intervention in the oral cavity (3-5). 
Thus, when certain odontologic procedures are done, it is 
very important to measure bleeding times of these patients 
in order to predict the possibilities of future bleeding and 
thus if  this oral procedure should be done or not. 
In recent years, the protocols on oral surgery procedures 
have undergone significant variations, modifying the me-
dical treatments of the patients based on the surgery times 
obtained from an analysis: bleeding time, protombin time, 
tissue thromblastin time and INR. It must be added to this 
that the usual diagnostic methods to know primary hemos-
tasis do not offer a simple, rapid and reproducible possibi-
lity on the platelet function (6-9). Assessment of primary 
hemostasis is very important not only for the diagnosis and 
management of patients with platelet disorders but also to 
measure the efficacy of antiaggregant therapy.
Bleeding time is that used to determine platelet function. 
The usual platelet tests are laborious and take time to do. 
The most frequent procedure used is the Ivy method (6). 
However, this is an invasive procedure that may be affected 
by different factors, that is not always well-accepted by the 
professionals and patients and that has many deficiencies 
(6, 9). That is why we present the Platelet Function Analy-
zer PFA-100 capable of measuring bleeding time in a few 
minutes, that can be an effective and comfortable alternative 
to the traditional methods as it is a simple method for the 
investigation of primary bleeding (10).
PLATELET ACTIVATION
They are several factors involved in the regulation of platelet 
thrombus formation. After the vascular lesion, platelets ad-
here to the subendothelium exposed through the von Wille-
brand factor that is bond to the glycoprotein Ib (GPIb) of 
the platelet membrane. After the adhesion and subsequent 
activation, they secrete the content of their granules, pro-
ducing platelet aggregation. This is a metabolic process in 
which the agonists released (thrombin or ADP) bind to their 
receptors on the surface of the platelets and stimulate them 
to expose binding sites for fibrinogen through GPIIb/IIIa. 
This also causes activation of the nearby platelets (3).
Furthermore, the modified membrane of the activated pla-
telets is exposed as a surface where the coagulation process 
takes place, generating thrombin as a final result which is, in 
turn, a powerful activator of the platelets. Finally, another 
important fact in clot formation is the production of throm-
boxane A2 by the platelets, a result of  arachidonic acid 
metabolism, a potent vasoconstrictor and platelet agonist.
The inhibitors of platelet function or antiaggregants block 
some or several of the previously mentioned mechanisms.
PRESENTATION OF PFA-100 SYSTEM
This is an improved device of Thrombostat 400 originally 
developed by Kratzer and Born in 1985 (8, 11-13). The 
platelet function analyzer PFA-100 (Fig. 1) simulates in 
vitro primary hemostasis in peripheral blood by a lesion of 
the membrane with collagen/ADP or collagen/epinephrine. 
This membrane, coated by approximately 50 mg of ADP 
and 10 mg of epinephrine, is protected in some cartridges 
perfectly identified with the initials COL/EPI or COL/ADP 
(Fig. 2). Collagen, epinephrine and ADP are, under in vivo 
physiological conditions, substances that favor platelet ad-
hesion and aggregation.
The system makes it possible two place both cartridges 
or one alone. Eight ml of the uncentrifuged blood sample 
must be pipetted in the smallest aperture of the cartridge, 
whole blood that should be collected in sodium citrate at 
3.8%-3.2%, used as anticoagulant (Fig. 3). When the device 
begins to process the sample, the blood is aspirated through 
a capillary towards the membrane (with a lesion of approxi-
mately 150 mm of aperture), crossing the orifice located in 
its center at an elevated speed (5000-6000/s). The analyzer 
calculates the time it takes to close the membrane lesion 
(CT) and thus measures the platelet function. The results 
are seen on the analyzer display and on printed paper that 
comes from the upper part of the apparatus. 
Maximum times for the closure of the membrane lesion are 
between 94-180 sec. for the collagen/epinephrine cartridge 
and between 71-119 sec. for the collagen/ADP one. 
Resultados: El valor medio del tiempo de hemorragia mediante el método Ivy fue de 406.36 sg. El tiempo de hemorragia 
medio con el sistema PFA-100 para el cartucho de colágeno/epinefrina fue de 226.91 sg. y para el cartucho de colágeno/
ADP fue de 110.27 sg. Todos estos valores se encuentran dentro de la normalidad. Observamos desviaciones típicas 
muy altas con el método Ivy y más regulares para el sistema PFA-100 indicando una mayor especificidad del mismo. 
Obtuvimos también una gran correlación entre el cartucho colágeno/epinefrina y el ácido acetil salicílico.
Conclusiones: Encontramos una mayor especificidad del analizador de función plaquetaria PFA-100 para la medición 
del tiempo de hemorragia en relación con el método tradicional Ivy.
Palabras clave: PFA, tiempo de hemorragia.
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Above these maximum times, the patient’s platelet function 
would be altered. Thus, PFA can measure if  the platelet 
function is normal, altered or even if  it does not finally pro-
duce any closure. Closure times for healthy children are gene-
rally longer than in adults but are not significant. However, 
neonates have significantly lower times than healthy children 
(6). The times in hemophilic patients are normal, indicating 
that factors 8 and 9 of coagulation are not involved in the 
formation of platelet plug formation (6, 14).
The typical pattern in patients antiaggregated with aspirin, 
of which the system is very specific, is: prolonged colla-
gen/epinephrine and normal collagen/ADP (6, 8, 9, 11, 
12). Thus, the col/epi cartridge is generally used to detect 
congenital platelet dysfunctions (e.g.: Von Willebrand di-
sease) and patients under treatment with aspirin while the 
col/ADP cartridge generally confirms dysfunction not due 
to ASA (15). 
Basically, the strongest factor involved in this system will 
be factor vW, primarily producing platelet adhesion by the 
Wf/FPIb system and later on the formation of the plug 
would involve vWF interaction with GPIIb/IIIa.
Most of the studies reviewed agree that PFA-100 is a simple, 
real and reproducible method to measure in vitro platelet 
function (6, 8, 9, 11, 12, 14, 16-18): Only Marshall et al. do 
not observed any advantage over the traditional method 
(13). Furthermore, PFA-100 is useful to evaluate platelet 
function in adults and above all in children. It is an excellent 
method of screening in patients with von Willebrand disease 
and in patients antiaggregated with aspirin.
OBJECTIVES
• Compare the traditional method of Ivy with the PFA-100 
device in order to determine which one is most specific when 
analyzing the platelet function.
• Discover if  the specific pattern of aspirin in the PFA-100 
analyzer is valid for any other platelet antiaggregant.
MATERIAL AND METHODS
A protocol was established to study the influence of platelet 
antiaggregants in oral surgical procedures, assessing blee-
ding time with two different methods: the traditional Ivy 
method and the PFA-100 system. The study was conducted 
in the Stomatology Service of the Fundación Jiménez Díaz 
on 33 patients whose ages ranged from 24-80 years in whom 
an oral surgical intervention had to be done. The patients 
were randomly distributed into two groups: one control 
group that interrupted antiaggregant treatment seven day 
before surgery and an experimental group that continued 
the therapy regularly. All the interventions were always done 
by the same surgeon.
- The enrolment criteria were:
• The patient should receive antiaggregant therapy regularly 
and continuously regardless of his/her age, gender, race, 
antiaggregant type or treatment dose.
• Patient who, fulfilling the previous condition, had to un-
dergo a surgical act in the oral cavity.
- The exclusion criteria were:
• Patients who also receive anticoagulant therapy.
• Patients in whom an abnormality is detected in coagulation 
time, that is, INR greater than 1.15.
• Patients with anemia with hemoglobin values under 
100g/l.
All the patients who agreed to collaborate in the study had to 
sign the corresponding informed consent. In the presurgical 
visit, a complete clinical history was obtained, including 
routine blood and biochemistry analyses, orthopantomo-
Fig. 1. Platelet Function Analyzer PFA-100.
Fig. 2. Collagen-Epinephrine Cartridge.
Fig. 3. COL/EPI cartridges with pipetting of blood sample 
in PFA-100.
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graphy and intraoral x-rays in order to assess the surgery 
type and provide pre-operative guidelines.
The prophylactic measures necessary were adopted based 
on the patient’s general condition. If  bacterial endocardi-
tis prophylaxis was necessary, 2 grams of oral amoxicillin 
were administered one hour before the surgical procedure. 
Patients allergic to penicillin received 600 mg of oral Clin-
damycin one hour before surgery.
Bleeding time and INR were obtained in all the patients 
one hour before the surgical procedure. Bleeding time was 
measured with the Ivy method and PFA-100 system. The 
INR was measured with an analysis conducted on the same 
day of the surgery and with the Coagucheck device one 
minute before the operation. The Ivy method was conduc-
ted in the Hematology Service of the Fundación Jiménez 
Díaz, making a small incision in the anterolateral surface 
of the forearm with an automated template, maintaining 
a pressure of  40 mmHg with the sphingomanometer. A 
filter paper was used every 15 to 30 seconds to collect the 
blood from the incision, but without entering into contact 
with it. Normal was considered to be between 180-540 sec 
(3-9 mn). All the data were recorded in the corresponding 
record of the patient
- Statistical method: The study of the discreet endpoints 
was done by frequency measured by contingency tables. 
We applied Pearson’s Chi-square to observe the existence or 
non-existence of significant differences in the different tables 
and correlations studied. Significance level is for p<0.05.
RESULTS
The study sample was made up of 33 patients, 7 women 
and 26 men, whose ages ranged from 24 to 80 years with 
mean age of 67.12 years (68.33 years in the control group 
and 66.66 years in the experimental group). Both groups 
can be considered homogeneous regarding the patients’ 
age (p= 0.756).
In regards to the type of platelet antiaggregant, only one 
patient (3%) was receiving treatment with acetylsalicylic 
acid (ASA) 100, 2 patients (6.1%) with ASA 150, 20 patients 
(60.6%) with ASA 300, 5 patients (15.2%) with clopidogrel 
and 5 other patients with ticlopidine. The patients also had 
a homogeneous distribution in both groups in regards to the 
type of antiaggregant they were taking (p= 0.238).
Bleeding time, measured with the Ivy method, had a mean 
value of  406.36 seconds (6.77 minutes): 353.33 seconds 
(5.88 minutes) in the control group and 426.25 seconds (7.10 
minutes) in the experimental group. Although, as was to be 
expected, bleeding time according to the Ivy method was 
greater in the experimental group, its values were found to 
be within the normality parameters (180-540 seconds: 3-9 
minutes). The statistical difference between the two groups 
was not significant (p=0.200).
Mean collagen/epinephrine bleeding time was 226.91 se-
conds: 176 seconds in the control group and 246 seconds in 
the experimental group (both within normality parameters: 
94-180 seconds). The difference between the two groups was 
significant (p=0.016). Mean collagen/ADP bleeding time 
was 110.27 seconds: 99.44 in the control group and 114.33 
seconds in the experimental group (normality parameters 
between 71-119 seconds).
Both in the control group and experimental one, we found 
very low and very high Ivy times. On the one hand, its p is 
equal to 0.200 (p>0.05), that is, the difference between both 
groups in relationship to bleeding time obtained by the Ivy 
method is not significant. Thus, we can state, a priori, that 
the Ivy method is not an adequate system when measuring 
bleeding time. It is a method with little specificity.
In table 1, we can see how the standard deviation is not as 
high for the bleeding times measured in both groups with 
the collagen/epinephrine cartridges. The times tend to be 
within normal parameters for the control group and above 
the maximum value considered as normal in the experimen-
tal group. After the statistical analysis, we found p=0.016 
(p<0.05), that is, it is a very specific system to measure 
bleeding time. Regarding bleeding time measured with 
collagen/ADP cartridges, the mean values in both groups 
were within normal parameters.
In regards to the correlations, we found the most important 
correlation between the times obtained with collagen/epi-
nephrine and collagen/ADP. When the time obtained with 
the col/epi cartridge is low or within normal limits, the time 
obtained with the col/ADP one would follow the same line. 
However, when the col/epi time is high (above the maximum 
considered normal), the col/ADP time will continue to be 
within normal parameters, although closer to the maximum 
limit. This correlation becomes more obvious when only 
those patients under treatment with ASA are included in 
the chart (Table 2). 
IVY EPINEPHRINE ADP 
IVY                     Pearson Correlation 
                             Sig(bilateral) 










EPINEPHRINE  Pearson Correlation 
                             Sig(bilateral) 










ADP                     Pearson Correlation 
                             Sig(bilateral) 











EPINEPHRINE     Pearson Correlation 
                               Sig(bilateral) 







ADP                      Pearson  Correlation 
                              Sig(bilateral) 
                               N 
.631**





** The correlation is significant at level of 0.01 (bilateral)
*   The correlation is significant at level of 0.05 (bilateral)
Table 1. Correlations between bleeding times, considering all the antia-
ggregants.
** The correlation is significant at level of 0.01 (bilateral)
Table 2. Correlation between collagen/epinephrine and collagen/ADP 
times in relationship to ASA.
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When the same charts are done including in one of them 
only those patients under treatment with clopidrogel and 
in the other only those treated with ticlopidine, we observe 
that there is a tendency to follow the same pattern as for 
aspirin, although the number of patients in the study under 
treatment with these two antiaggregants is still scarce.
DISCUSSION
PFA-100, as we have described, is a method that has been 
demonstrated to be effective fundamentally for the asses-
sment of antiaggregated patients and for the diagnosis of 
hereditary platelet dysfunctions: von Willebrank disease, 
Glanzmann thrombasthenia and Bernard-Soulier syndrome 
(18-21) but less effective in patients with unknown hemos-
tatic disorders, bleeding time being even more sensitive in 
these (20). The protein most involved in platelet aggregation 
by this system is factor vW. This interacts with the platelet 
glycoprotein Ib/IX and IIb/IIIa receptors. Meanwhile, it 
has been demonstrated how fibrinogen practically does 
not exert any function (8, 12, 14, 15, 18, 22), perhaps due 
to the elevated speeds acquired through the membrane 
(5000-6000/s).
For the study of  bleeding time, we have not found any 
study whose objective is to assess the repercussion of the 
antiaggregants in the oral surgical procedures by using the 
PFA-100 system. The studies and cases consulted (3, 5, 
23-26) use the traditional methods, fundamentally the Ivy 
method. However, there are abundant studies applied to 
other fields of medicine that consider PFA as a rapid me-
thod, a simple one that does not require qualified operators, 
with low cost and with extensive advantages: use of whole 
blood, obtaining of results in real time (approximately 10 
mm), accuracy of measurements and use of small amounts 
of blood (0.8 ml per cartridge), which makes it very useful 
in pediatric patients (6, 8, 12, 22). Compared to this, the 
disadvantages presented by the traditional methods have 
been indicated. These are: being extremely dependent on the 
operator, being invasive (difficulty in pediatric patients), they 
may not predict bleeding time in presurgical patients, they 
may offer normal values in presence of severe abnormalities 
and may be difficult to reproduce (6,9). Thus, the PFA has 
been indicated as a useful screening method, although it 
may have certain limitations. Blood should only be treated 
with citrate and not with PRP. The results may vary accor-
ding to the citrate concentrations (closure time decreases 
when the citrate concentrations are lower) or according to 
the grade of the calcium chelate of the anticoagulant (11), 
existence of a correlation between hematocrit and closure 
time with epinephrine (9) and low hematocrits (<30%) and 
that decreased platelet counts (<50 109/1) could result in 
a prolongation of closure time (14). Furthermore, it may 
not be as sensitive in detecting ADP platelet antagonists 
(27), showing a relative utility in this field, being a mere 
complement to the aggregometry (21).
In our study, after analyzing the results, we agree with other 
authors that the Platelet Function Analyzer is more specific 
and reliable than the Ivy method to determine bleeding 
time (6, 8, 9, 11-14, 16-19, 28). However, authors such as 
Marshall et al. find equal sensitivity and reproducibility of 
PFA in relationship with the Ivy method. They also claim 
that the device may provide slightly superior results than 
those expected, which they interpret as false positives (13). 
Another study (29) states how a significant proportion of 
patients under treatment with ASA show a normal platelet 
function measured by PFA, the elderly and women being 
the most prone to show a decreased therapeutic response 
to aspirin.
We also agree that the typical pattern in patients antiaggre-
gated with ASA is prolonged col/epi and col/ADP within the 
normality limits  (6, 8, 11, 12). However, it must be stated 
that mean time of collagen/epinephrine in the control group 
patients (whose treatment was temporally interrupted) was 
very close to the maximum parameter. This could explain 
why the antiaggregant was withdrawn 7 days before the 
extraction. However, we know that these drugs produce an 
irreversible action on the platelets, whose half  life is 9-10 
days. An alteration in the col/APD cartridge in patients 
treated with aspirin would indicate a platelet alteration 
having high severity (12).
    In spite of the limited sample of our study regarding 
patients who took clopidogrel (5 patients) and ticlopidine 
(5 more), we observe that there is a tendency to follow the 
same pattern as acetylsalicylic acid. Some authors (11, 30) 
do not find significantly altered values in patients treated 
with ASA/Ticlopidine or ticlopidine alone in the PFA 
method. However, they do find a prolongation in platelet 
aggregation with ADP. However, a longer closure time with 
clopidrogel was found with the PFA system (30).
Conclusions:
- The platelet function analyzer PFA-100 is more specific 
and less invasive to measure bleeding time than the tradi-
tional method of Ivy.
- The PFA-100 is a very specific device for ASA, with which 
a characteristic pattern is followed.
-  Investigation should continue in relationship to its efficacy 
in patients treated with other platelet antiaggregants other 
than ASA and its response pattern regarding them should 
be identified.
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